Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar solanZRaider (< 20) Submitted: 11/21/2011 10:05:17 AM : Outperform Start Price: $35.85 GILD Score: +30.27

Anvil13

Report this Post Reply

Featured Broker Partners


Advertisement